Malaria Vaccines Market driven by growing prevalence of malaria

The malaria vaccines market has been growing significantly over the past decade due to the rising prevalence of malaria. According to WHO, around 229 million cases of malaria were reported globally in 2019. Malaria is caused by Plasmodium parasites that are transmitted to humans through the bites of infected Anopheles mosquitoes. The most affected regions include Africa south of the Sahara, Asia, and Latin America. Current therapies against malaria include antimalarial drugs, insecticides, and bed nets. However, these measures have limitations, thereby boosting the demand for vaccines that can offer effective prevention against all strains of malaria parasites.

 Get More insights on Malaria Vaccines Market https://articlescad.com/ma...